Cargando…
Comparative cell biological study of in vitro antitumor and antimetastatic activity on melanoma cells of GnRH-III-containing conjugates modified with short-chain fatty acids
Background: Peptide hormone-based targeted tumor therapy is an approved strategy to selectively block the tumor growth and spreading. The gonadotropin-releasing hormone receptors (GnRH-R) overexpressed on different tumors (e.g., melanoma) could be utilized for drug-targeting by application of a GnRH...
Autores principales: | Lajkó, Eszter, Spring, Sarah, Hegedüs, Rózsa, Biri-Kovács, Beáta, Ingebrandt, Sven, Mező, Gábor, Kőhidai, László |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Beilstein-Institut
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6178282/ https://www.ncbi.nlm.nih.gov/pubmed/30344773 http://dx.doi.org/10.3762/bjoc.14.226 |
Ejemplares similares
-
Apoptotic Effects of Drug Targeting Conjugates Containing Different GnRH Analogs on Colon Carcinoma Cells
por: Lajkó, Eszter, et al.
Publicado: (2019) -
Enhanced In Vitro Antitumor Activity of GnRH-III-Daunorubicin Bioconjugates Influenced by Sequence Modification
por: Schuster, Sabine, et al.
Publicado: (2018) -
Drug targeting to decrease cardiotoxicity – determination of the cytotoxic effect of GnRH-based conjugates containing doxorubicin, daunorubicin and methotrexate on human cardiomyocytes and endothelial cells
por: Polgár, Livia, et al.
Publicado: (2018) -
Effects of Gonadotropin-Releasing Hormone (GnRH) and Its Analogues on the Physiological Behaviors and Hormone Content of Tetrahymena pyriformis
por: Lajkó, Eszter, et al.
Publicado: (2019) -
Synthesis and in vitro biochemical evaluation of oxime bond-linked daunorubicin–GnRH-III conjugates developed for targeted drug delivery
por: Schuster, Sabine, et al.
Publicado: (2018)